Clinical trial · Observational
Quantitative Analysis of 18F-FAPI Dynamic PET/CT for Accurate Differential Diagnosis of MLN of ESCC
Quantitative Analysis of 18F-FAPI Dynamic PET/CT for Accurate Differential Diagnosis of Metastatic Lymph Nodes of Esophageal Squamous Cell Carcinoma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients diagnosed with esophageal squamous cell carcinoma based on clinicopathology, laboratory examination and imaging criteria were selected as the research subjects, and compared with conventional 18F-FDG PET/CT. To evaluate the research value of quantitative analysis of 18F-FAPI PET/CT dynamic imaging in the classification of benign and malignant features of primary esophageal squamous cell carcinoma (ESCC) and lymphatic nodules, lesion localization, outcome and prognosis.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Benign Lymph Node Neoplasm | Benign Lymph Node Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Esophageal Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Malignant Lymph Node Neoplasm | Malignant Lymph Node Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dynamic PET/CT | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Non-N0 stage
- description
- Patients with malignant lymph nodes.
- interventionNames
- Diagnostic Test: Dynamic PET/CT
- label
- N0 stage
- description
- Patients without malignant lymph nodes.
- interventionNames
- Diagnostic Test: Dynamic PET/CT
Primary outcomes (6)
- measure
- Comparison of SUVmax between MLN and BLN.
- timeFrame
- 50 min to 60 min
- description
- Comparison of SUVmax between MLN and BLN.
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: 1. Esophageal squamous cell carcinoma was diagnosed according to gastroscopy and pathological diagnostic criteria; 2. Age above 18 years old, less than 85 years old, no gender restriction; 3. Untreated patients who have not received surgery, chemotherapy, biotherapy or radiotherapy; 4. Laboratory examination: (1) General physical condition score ECOG: 0-2; (2) No dysfunction of main organs; (3) Oxygen partial pressure ≥ 10.64kPa; (4) WBC ≥ 4×109 L-1; (5) Routine blood hemoglobin ≥ 9.5 g· DL-1; (6) The absolute count of neutrophils ≥ 1.5×109 L-1; (7) Platelet count ≥ 100×109 L-1; (8) Total bilirubin ≤ 1.5 times the upper limit of normal value; (9) Creatinine ≤ 1.25 times the upper limit of normal value; (10) Creatinine clearance rate ≥ 60 mL ·min-1; 5\. Can obtain complete follow-up information, understand the situation of this study and sign the informed consent. Exclusion Criteria: 1. Has had any other malignant tumor within 5 years; 2. Nursing and/or pregnant women; 3. Patients with severe bleeding tendency; 4. Recent severe hemoptysis, severe cough, dyspnea or patients cannot cooperate; 5. Severe emphysema, pulmonary congestion and cor pulmonale; 6. In the opinion of the Investigator, the subject may not be able to complete the study or comply with the requirements of the study (for administrative or other reasons).
References
Publications (0)
Data not yet available